Wuhu Token Sciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	11,341	11,020	8,770	6,911	6,956	6,735
Other Revenue	37.54	37.54	118.78	76.32	62.71	109.13
Revenue	11,379	11,058	8,889	6,987	7,018	6,844
Revenue Growth (YoY)	1.33%	24.40%	27.21%	-0.44%	2.55%	13.62%
Cost of Revenue	10,177	10,075	8,047	5,696	5,380	5,046
Gross Profit	1,202	982.31	842.05	1,291	1,638	1,798
Selling, General & Admin	393.13	341.39	289.52	317.5	284.69	266.22
Research & Development	460.11	428.59	334.14	330.02	301.59	267.74
Other Operating Expenses	-47.99	-37.14	-18.48	44.86	34.05	47.96
Operating Expenses	817.02	661.12	636.76	694.9	643.75	601.98
Operating Income	385.21	321.2	205.29	595.9	994.3	1,196
Interest Expense	-76.65	-73.41	-45.02	-22.97	-28.74	-43.58
Interest & Investment Income	31.32	59.27	49.12	21.22	45.48	22.97
Currency Exchange Gain (Loss)	30.87	30.87	34.16	106.48	-31.51	-84.24
Other Non Operating Income (Expenses)	3.52	-4.23	-0.72	-2.29	6.05	-8.19
EBT Excluding Unusual Items	374.26	333.71	242.82	698.34	985.6	1,083
Impairment of Goodwill	-	-	-16.79	-	-11.33	-
Gain (Loss) on Sale of Investments	0.15	0.17	-51.92	-23.79	-0.02	-152.46
Gain (Loss) on Sale of Assets	1.5	6.59	54.13	-10.93	-1.61	0.57
Asset Writedown	-43.83	-1.13	-0.4	-10.66	-0.08	-0.43
Other Unusual Items	21.17	21.17	88.55	76.65	87.19	63.72
Pretax Income	353.26	360.51	316.4	729.6	1,060	994.41
Income Tax Expense	18.83	-6.29	20.72	17.21	126.82	144
Earnings From Continuing Operations	334.43	366.8	295.68	712.39	932.93	850.42
Minority Interest in Earnings	14.92	-10.01	-54.11	-32.73	-28.69	-16.19
Net Income	349.34	356.79	241.56	679.66	904.24	834.23
Net Income to Common	349.34	356.79	241.56	679.66	904.24	834.23
Net Income Growth	52.61%	47.70%	-64.46%	-24.84%	8.39%	-1.32%
Shares Outstanding (Basic)	2,384	2,379	2,416	2,427	2,444	2,454
Shares Outstanding (Diluted)	2,384	2,379	2,416	2,427	2,512	2,454
Shares Change (YoY)	-1.32%	-1.53%	-0.48%	-3.36%	2.37%	1.58%
EPS (Basic)	0.15	0.15	0.10	0.28	0.37	0.34
EPS (Diluted)	0.15	0.15	0.10	0.28	0.36	0.34
EPS Growth	54.65%	50.00%	-64.29%	-22.22%	5.88%	-2.86%
Free Cash Flow	206.07	-750.44	-638.05	369.86	-186.68	917.56
Free Cash Flow Per Share	0.09	-0.32	-0.26	0.15	-0.07	0.37
Dividend Per Share	0.060	0.060	0.070	0.100	0.050	0.100
Dividend Growth	-14.29%	-14.29%	-30.00%	100.00%	-50.00%	-0.00%
Gross Margin	10.56%	8.88%	9.47%	18.47%	23.34%	26.27%
Operating Margin	3.38%	2.90%	2.31%	8.53%	14.17%	17.48%
Profit Margin	3.07%	3.23%	2.72%	9.73%	12.88%	12.19%
Free Cash Flow Margin	1.81%	-6.79%	-7.18%	5.29%	-2.66%	13.41%
EBITDA	1,040	1,042	1,014	1,261	1,585	1,694
EBITDA Margin	9.14%	9.42%	11.41%	18.05%	22.59%	24.75%
D&A For EBITDA	654.41	720.54	808.72	665.2	591.11	498.02
EBIT	385.21	321.2	205.29	595.9	994.3	1,196
EBIT Margin	3.38%	2.90%	2.31%	8.53%	14.17%	17.48%
Effective Tax Rate	5.33%	-	6.55%	2.36%	11.97%	14.48%
Revenue as Reported	11,379	11,058	8,889	6,987	7,018	6,844

Source: S&P Global Market Intelligence. Standard template. Financial Sources.